Reverse DCF
What growth does the market imply for GPTHEALTH?
Working backwards from the current price to find the FCF growth assumption baked in.
reasonable
14.6% implied annual FCF growth
The market's growth assumption looks achievable — it is in line with or below what this company has historically delivered.
Current Price
₹148
Historical Growth
13.4%
FCF Yield
3.24%
Price / FCF
30.9x
Plain English
To justify today's price of ₹148.17, GPTHEALTH.NS needs to grow its free cash flow at 14.6% per year for the next 10 years. That is 1.2% faster than its historical growth rate of 13.4%. This looks achievable — the market is not pricing in heroic assumptions. There may be genuine upside if the company executes.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| Half implied | 7.3% | ₹80 | -45.9% |
| GDP rate | 10.0% | ₹101 | -31.9% |
| Historical | 13.4% | ₹134 | -9.2% |
| Implied | 14.6% | ₹148 | +0.0% |
At Historical Growth Rate
DCF horizon: 10 years. At 13.4% growth, the model values GPTHEALTH at ₹134, below today's ₹148.
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, reverse DCF, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.